HISTIDE

histide-logo

Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules™ (CRMs). This innovative platform builds on Histide’s expertise in the mechanisms underlying the cell’s microenvironmental sensing and signal transduction processes. The CRMs promote and stimulate the cell’s natural capacities to redirect its own fate by integrating accurate extracellular signals. This is at the heart of Histi... de’s groundbreaking approach of addressing diseases called Recoding Therapeutics™, that goes beyond traditional cell, gene or RNA based therapies. Histide has a technological breakthrough with vast indication spectra of pharmaceuticals, medical devices and medical cosmetics. Their mission : Establish Cell Recoding Molecules (CRMs) as new class of therapeutic solutions. Their vision : To unlock the potential of Recoding Therapeutics by establishing an ecosystem of teams and partners, all committed to providing enhanced therapeutic solutions across diverse areas and routes of administration, for diseases that are untreatable or undruggable today.

#SimilarOrganizations #People #Financial #Website #More

HISTIDE

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2014-01-01

Address:
Schindellegi, Schwyz, Switzerland

Country:
Switzerland

Website Url:
http://www.histide.com

Total Employee:
11+

Status:
Active

Contact:
+41 43 888 2577

Email Addresses:
[email protected]

Total Funding:
4.5 M CHF

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Apache


Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.


Current Advisors List

not_available_image

Romain Julia Chairman of The Board of Director @ Histide
Board_member

not_available_image

Omar Zouani Chairman of the Board of Directors @ Histide
Board_member
2020-06-01

Current Employees Featured

not_available_image

Romain Julia
Romain Julia Founder @ Histide
Founder
2014-03-01

not_available_image

Omar Zouani
Omar Zouani Chief Executive Officer @ Histide
Chief Executive Officer
2016-11-01

Founder


not_available_image

Omar Zouani

not_available_image

Romain Julia

Investors List

partner-capital_image

Partner Capital

Partner Capital investment in Series A - Histide

Official Site Inspections

http://www.histide.com

  • Host name: cluster014.ovh.net
  • IP address: 213.186.33.87
  • Location: Saran France
  • Latitude: 47.9531
  • Longitude: 1.871
  • Timezone: Europe/Paris
  • Postal: 45770

Loading ...

More informations about "Histide"

Histide

Histideâ„¢ s a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ (CRM). This …See details»

Histide - Crunchbase Company Profile & Funding

Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding …See details»

Histide 2025 Company Profile: Valuation, Funding & Investors

Histide General Information Description. Developer of a biotech intellectual property platform designed to introduce a new class of non-mutagenic extracellular technology. The company's …See details»

Histide - 2025 Company Profile, Funding & Competitors - Tracxn

May 5, 2025 Histide - Biotechnology startup developing novel therapeutics and cosmetics based on proprietary Cell Recoding platform. Raised a total funding of $4.6M over 1 round from 2 …See details»

Histide - LinkedIn

Histideâ„¢ is pioneering Recoding Therapeuticsâ„¢, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the …See details»

Histide - Products, Competitors, Financials, Employees, …

Histide has launched several preclinical programs in pharma and medical device indications. About Histide AG Histideâ„¢ is a biotech intellectual property platform company pioneering a …See details»

Histide AG - Schindellegi, Switzerland - bionity.com

Histideâ„¢ is pioneering Recoding Therapeuticsâ„¢, a novel therapy using non-mutagenic extracellular technologies to direct cell fate. Based on the universal understanding of the …See details»

Histide Company Profile - Office Locations, Competitors ... - Craft

Histide has 5 employees across 2 locations. See insights on Histide including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Histide - Overview, News & Similar companies | ZoomInfo.com

Who is Histide. Histideâ„¢ is a biotech intellectual property platform company pioneering a new class of nonmutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ …See details»

Histide AG - VentureRadar

Histide’s pipeline of investigational Recoding therapeutics is focused in 5 Strategic Therapeutic Areas: Oncology, with a pipeline of CRMs that trigger the tumor cells to switch to healthy cells; …See details»

Nextsource | Company Profile | Histide

Explore the company profile of Histide (histide.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

Histide AG - Drug pipelines, Patents, Clinical trials - Synapse

100 Translational Medicine associated with Histide AG. Login to view more data. Corporation Tree. Boost your research with our corporation tree data. login. or. view full example data. …See details»

Histide | EU-Startups

Histide is a biotech intellectual property platform company pioneering a new class of non-mutagenic extracellular therapeutic agents called Cell Recoding Moleculesâ„¢ (CRMs).See details»

HISTIDE AG Company Profile | Schindellegi, SCHWYZ, Switzerland ...

Find company research, competitor information, contact details & financial data for HISTIDE AG of Schindellegi, SCHWYZ. Get the latest business insights from Dun & Bradstreet.See details»

Histide - Contacts, Employees, Board Members, Advisors & Alumni

Histide is a biotech intellectual property platform. Start Free Trial . Chrome ExtensionSee details»

Histide AG - Company Profile and News - Bloomberg Markets

Company profile page for Histide AG including stock price, company news, executives, board members, and contact informationSee details»

Histide - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 10, 2014: Series A - …See details»

Histide Management Team - CB Insights

Explore {Histide's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Histide CEO, Founder, Key Executive …See details»

Romain Julia - Founder @ Histide - Crunchbase Person Profile

Primary Organization . Histide . Location Zürich, Zurich, Switzerland; Regions Europe, Middle East, and Africa (EMEA) ... Prior to founding Histide with Dr. OF. Zouani,Julia acquired more …See details»

Inside the Heritage Foundation’s Plan to Crush the U.S. Palestinian ...

2 days ago Even before President Trump was re-elected, the Heritage Foundation, best known for Project 2025, set out to destroy pro-Palestinian activism in the United States.See details»

linkstock.net © 2022. All rights reserved